Apexigen, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2021 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Apexigen, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2022.
  • Apexigen, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $2.3M, a 10852% increase year-over-year.
  • Apexigen, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $2.3M +$2.28M +10852% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-23
Q1 2021 $21K Jan 1, 2021 Mar 31, 2021 10-Q 2021-06-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.